Exact Mass: 577.1953846
Exact Mass Matches: 577.1953846
Found 141 metabolites which its exact mass value is equals to given mass value 577.1953846
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Clazosentan
C28313 - Endothelin Receptor Antagonist Clazosentan (Ro 61-1790) is a selective endothelin A (ETA) receptor antagonist. Clazosentan inhibits ET-1-mediated vasoconstriction. Clazosentan prevents cerebral vasospasm, vasospasm-related cerebral infarction[1][5].
Cys His Arg Tyr
Cys His Tyr Arg
Cys Asn Arg Trp
Cys Asn Trp Arg
Cys Arg His Tyr
Cys Arg Asn Trp
Cys Arg Trp Asn
Cys Arg Tyr His
Cys Trp Asn Arg
Cys Trp Arg Asn
Cys Tyr His Arg
Cys Tyr Arg His
Asp Glu Glu Trp
Asp Glu Trp Glu
Asp Trp Glu Glu
Glu Asp Glu Trp
Glu Asp Trp Glu
Glu Glu Asp Trp
Glu Glu Trp Asp
Glu Trp Asp Glu
Glu Trp Glu Asp
His Cys Arg Tyr
His Cys Tyr Arg
His Met Gln Tyr
C25H35N7O7S (577.2318560000001)
His Met Tyr Gln
C25H35N7O7S (577.2318560000001)
His Gln Met Tyr
C25H35N7O7S (577.2318560000001)
His Gln Tyr Met
C25H35N7O7S (577.2318560000001)
His Arg Cys Tyr
His Arg Tyr Cys
His Tyr Cys Arg
His Tyr Met Gln
C25H35N7O7S (577.2318560000001)
His Tyr Gln Met
C25H35N7O7S (577.2318560000001)
His Tyr Arg Cys
Met His Gln Tyr
C25H35N7O7S (577.2318560000001)
Met His Tyr Gln
C25H35N7O7S (577.2318560000001)
Met Asn Gln Trp
C25H35N7O7S (577.2318560000001)
Met Asn Trp Gln
C25H35N7O7S (577.2318560000001)
Met Gln His Tyr
C25H35N7O7S (577.2318560000001)
Met Gln Asn Trp
C25H35N7O7S (577.2318560000001)
Met Gln Trp Asn
C25H35N7O7S (577.2318560000001)
Met Gln Tyr His
C25H35N7O7S (577.2318560000001)
Met Trp Asn Gln
C25H35N7O7S (577.2318560000001)
Met Trp Gln Asn
C25H35N7O7S (577.2318560000001)
Met Tyr His Gln
C25H35N7O7S (577.2318560000001)
Met Tyr Gln His
C25H35N7O7S (577.2318560000001)
Asn Cys Arg Trp
Asn Cys Trp Arg
Asn Met Gln Trp
C25H35N7O7S (577.2318560000001)
Asn Met Trp Gln
C25H35N7O7S (577.2318560000001)
Asn Gln Met Trp
C25H35N7O7S (577.2318560000001)
Asn Gln Trp Met
C25H35N7O7S (577.2318560000001)
Asn Arg Cys Trp
Asn Arg Trp Cys
Asn Trp Cys Arg
Asn Trp Met Gln
C25H35N7O7S (577.2318560000001)
Asn Trp Gln Met
C25H35N7O7S (577.2318560000001)
Asn Trp Arg Cys
Gln His Met Tyr
C25H35N7O7S (577.2318560000001)
Gln His Tyr Met
C25H35N7O7S (577.2318560000001)
Gln Met His Tyr
C25H35N7O7S (577.2318560000001)
Gln Met Asn Trp
C25H35N7O7S (577.2318560000001)
Gln Met Trp Asn
C25H35N7O7S (577.2318560000001)
Gln Met Tyr His
C25H35N7O7S (577.2318560000001)
Gln Asn Met Trp
C25H35N7O7S (577.2318560000001)
Gln Asn Trp Met
C25H35N7O7S (577.2318560000001)
Gln Trp Met Asn
C25H35N7O7S (577.2318560000001)
Gln Trp Asn Met
C25H35N7O7S (577.2318560000001)
Gln Tyr His Met
C25H35N7O7S (577.2318560000001)
Gln Tyr Met His
C25H35N7O7S (577.2318560000001)
Arg Cys His Tyr
Arg Cys Asn Trp
Arg Cys Trp Asn
Arg Cys Tyr His
Arg His Cys Tyr
Arg His Tyr Cys
Arg Asn Cys Trp
Arg Asn Trp Cys
Arg Trp Cys Asn
Arg Trp Asn Cys
Arg Tyr Cys His
Arg Tyr His Cys
Trp Cys Asn Arg
Trp Cys Arg Asn
Trp Asp Glu Glu
Trp Glu Asp Glu
Trp Glu Glu Asp
Trp Met Asn Gln
C25H35N7O7S (577.2318560000001)
Trp Met Gln Asn
C25H35N7O7S (577.2318560000001)
Trp Asn Cys Arg
Trp Asn Met Gln
C25H35N7O7S (577.2318560000001)
Trp Asn Gln Met
C25H35N7O7S (577.2318560000001)
Trp Asn Arg Cys
Trp Gln Met Asn
C25H35N7O7S (577.2318560000001)
Trp Gln Asn Met
C25H35N7O7S (577.2318560000001)
Trp Arg Cys Asn
Trp Arg Asn Cys
Tyr Cys His Arg
Tyr Cys Arg His
Tyr His Cys Arg
Tyr His Met Gln
C25H35N7O7S (577.2318560000001)
Tyr His Gln Met
C25H35N7O7S (577.2318560000001)
Tyr His Arg Cys
Tyr Met His Gln
C25H35N7O7S (577.2318560000001)
Tyr Met Gln His
C25H35N7O7S (577.2318560000001)
Tyr Gln His Met
C25H35N7O7S (577.2318560000001)
Tyr Gln Met His
C25H35N7O7S (577.2318560000001)
Tyr Arg Cys His
Tyr Arg His Cys
NAPHTHOL AS-MX-PHOSPHATE DISODIUM SALT NONAHYDRATE
C19H34NNa2O14P (577.1512233999999)
N-(2-(((3S,4S)-1-(4-(BENZO[D][1,3]DIOXOL-5-YL)-4-HYDROXYCYCLOHEXYL)-4-ETHOXYPYRROLIDIN-3-YL)AMINO)-2-OXOETHYL)-3-(TRIFLUOROMETHYL)BENZAMIDE
C29H34F3N3O6 (577.2399580000001)
NEU5AC ALPHA(2-3)GAL BETA MP GLYCOSIDE
C24H35NO15 (577.2006600000001)
ethyl (2R,4R)-1-[(2S)-5-[[amino(nitramido)methylidene]amino]-2-[(3-methylquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylate
C25H35N7O7S (577.2318560000001)
Phenylmethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3-O-(phenylmethyl)-4,6-O-[(R)-phenylmethylene]-beta-D-glucopyranoside
Clazosentan
C28313 - Endothelin Receptor Antagonist Clazosentan (Ro 61-1790) is a selective endothelin A (ETA) receptor antagonist. Clazosentan inhibits ET-1-mediated vasoconstriction. Clazosentan prevents cerebral vasospasm, vasospasm-related cerebral infarction[1][5].
6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-7-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-5-olate
C27H29O14- (577.1557233999999)
2-[[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]-oxomethyl]imino-1-(2-methylpropyl)-5-oxo-3-dipyrido[1,2-d:3,4-f]pyrimidinecarboxylic acid ethyl ester
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
vitexin 2-O-alpha-L-rhamnoside(1-)
C27H29O14- (577.1557233999999)
The conjugate base of vitexin 2-O-alpha-L-rhamnoside arising from deprotonation of the OH group at position 7 on the chromene.
vitexin 2-O-beta-L-rhamnoside(1-)
A flavonoid oxoanion that is the conjugate base of vitexin 2-O-beta-L-rhamnoside obtained by deprotonation of the OH group at position 7 on the chromene. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).